arrow
L

Lim, Young-Suk

university of ulsan
H指数:0
被引数:158

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol

多中心前瞻性试验:比较使用钆塞酸缩短扫描时间的MRI与CT对晚期复发性肝癌的检测(AMRICT研究方案)

2026-04-240
OA
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial

Elbsiran和PEG-IFNα用于慢性乙型肝炎感染:一项部分随机、开放标签、II期试验

2025-11-070
OAAI
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

东亚人种慢性乙型肝炎患者中,Tenofovir Alafenamide (TAF) 和 Tenofovir Disoproxil Fumarate (TDF) 随后转换为 TAF 治疗5年的疗效与安全性。

2025-08-120
OAAI
Phase Ib/IIa randomized study of heterologous ChAdOx1HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB
2024-12-010
PRE
Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B A Multinational Study for the Development and External Validation of a New Prognostic Model
2024-10-011
PRE
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
2024-09-272
OAAI